UPDATE : Monday, September 7, 2020
상단여백
GC sells off North America business to Grifols
GC said that it has sold off its Montreal-based GC Biotherapeutics’ plasma ...
by Lee Han-soo  |  2020-07-21 18:31
라인
Helixmith to start trials of VM202 for treating rare disorder
Helixmith said that it has kicked off its phase 1 and 2a clinical trial for...
by Lee Han-soo  |  2020-07-21 17:10
라인
Genexine, Y Biologics to co-develop Covid-19 treatment
Genexine said that it would develop an antibody-based Covid-19 treatment, j...
by Lee Han-soo  |  2020-07-21 15:52
라인
GC LabCell’s tech wins patent for delivering gene therapy to brain
GC Labcell said Tuesday that it obtained a domestic patent for a compositio...
by Shim Hyun-tai  |  2020-07-21 15:52
라인
'Severe atopic dermatitis drug too expensive for adolescents'
The drug regulator expanded approval for Dupixent (ingredient: dupilumab), ...
by Kim Eun-young  |  2020-07-21 14:20
라인
GC makes plasma Covid-19 therapy for clinical trials
GC Pharma has taken the first step to commercialize its new plasma treatmen...
by Shim Hyun-tai  |  2020-07-20 17:30
라인
Eutilex’s cancer therapy won Canadian patent
Eutilex, a biotechnology firm specializing in cancer immunotherapy, said Fr...
by Shim Hyun-tai  |  2020-07-17 17:52
라인
Hanmi’s fatty liver drug won FDA’s fast-track designation
Hanmi Pharmaceutical said Thursday that the U.S. Food and Drug Administrati...
by Shim Hyun-tai  |  2020-07-16 15:57
라인
‘Stage-3 unresectable lung cancer patient has every reason to use Imfinzi’
“Before Imfinzi arrived, all physicians could do for a state-3 unresectable...
by Kim Yun-mi  |  2020-07-16 14:37
라인
Menarini Korea deletes controversial YouTube ad
Menarini Korea’s online advertisement of an athlete’s foot treatment depict...
by Kim Chan-hyuk  |  2020-07-16 14:16
라인
Samsung Biologics to develop 5 more cancer therapies of ImmuneOncia
Samsung Biologics said Wednesday that it has signed a CDO (contract develop...
by Shim Hyun-tai  |  2020-07-15 18:33
라인
Biogen, Esai to test another Alzheimer’s drug in phase-3 study
Biogen and Eisai, whose collaboration for experimental Alzheimer’s drug adu...
by Kim Yun-mi  |  2020-07-15 12:42
라인
Medytox, Daewoong keep brawling over US agency’s ruling
Medytox and Daewoong Pharmaceutical continued to brawl over the U.S. Intern...
by Lee Han-soo  |  2020-07-14 17:30
라인
Hanmi Science, Bioapp to start full-scale development of Green bio-based COVID-19 vaccine
Hanmi Science (CEO Lim Chong-yoon, Hanmi Group Holding Company) and a promi...
by Lee Han-soo  |  2020-07-14 14:58
라인
LSK Global PS chosen as CRO of IVI's Covid-19 vaccine trials
LSK Global Pharma Services (PS) said that it would conduct and support the ...
by Lee Han-soo  |  2020-07-13 15:48
라인
‘Remdesivir cut death risk by 62% in severely ill Covid-19 patients’
Gilead Sciences said its Covid-19 drug candidate remdesivir reduced the ris...
by Kim Yun-mi  |  2020-07-13 14:44
라인
Regulator OKs Samyang’s breast cancer treatment
Samyang Biopharmaceuticals said that the Ministry of Food and Drug Safety h...
by Lee Han-soo  |  2020-07-13 14:38
라인
Multinational drugmakers seek to form new trade union
Some workers at the Korean offshoots of multinational pharmaceutical compan...
by Kim Yun-mi  |  2020-07-13 11:44
라인
Ministry OKs Dongkook's P3 trial into benign prostatic hyperplasia treatment
Dongkook Pharmaceutical said that the Ministry of Food and Drug Safety has ...
by Lee Han-soo  |  2020-07-10 16:54
라인
Court rejects Medytox's request not to revoke license of Medytoxin
A local court on Wednesday has turned down Medytox's appeal for suspend...
by Lee Han-soo  |  2020-07-10 14:59
여백
여백
여백
Back to Top